Ultime notizie per eHealth (NASDAQ:EHTH) Azioni

eHealth

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.

eHealth Inc

<h2>CMS Rolls Out Aggressive Strategy to Enhance and Accelerate Medicare Advantage Audits</h2>

Biotech

News

General

CLOV

EHTH

ELEV

GOCO

'CMS Rolls Out Aggressive Strategy To Enhance And Accelerate Medicare Advantage Audits; Agency Will Begin Auditing All Eligible Medicare Advantage Contracts Each Payment Year And Add Resources To Expedite Completion Of 2018 To 2024 Audits'

RBC Capital analyst Ben Hendrix reiterates eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Sector Perform and maintains $11 price target.

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Sector Perform on eHealth, Maintains $11 Price Target

UBS analyst Jonathan Yong maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Neutral and lowers the price target from $9.5 to $7.

UBS Maintains Neutral on eHealth, Lowers Price Target to $7

WIIM

eHealth shares are trading higher after the company reported better-than-expected Q1 financial results.

Guidance

eHealth Affirms FY2025 Sales Guidance of $510.00M-$550.00M vs $529.17M Est

Earnings

Earnings Beats

eHealth Q1 Adj. EPS $(0.20) Beats $(0.42) Estimate, Sales $113.12M Beat $99.63M Estimate

ACAD

ACDC

ACRE

ACVA

ADMA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

ALVO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AVDX

AXON

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENT

CENTA

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CVNA

CYRX

Earnings Scheduled For May 7, 2025

SLQT

Shares of eHealth, GoHealth and SelectQuote are trading lower after the US filed a False Claims Act complaint against the companies.

<a href="https://www.justice.gov/opa/media/1398796/dl" title="https://www.justice.gov/opa/media/1398796/dl">https://www.justice.gov/opa/media/1398796/dl</a>

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

DOJ Says U.S. Alleges Aetna And Humana Each Conspired With Broker Defendants To Discriminate Against Medicare Beneficiaries With Disabilities; U.S Alleges Defendant Insurers Paid Hundreds Of Millions Of Dollars In Illegal Kickbacks To The Defendant Brokers

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) sees FY2025 sales of $510.000 million-$550.000 million vs $528.54 million analyst estimate.

eHealth Sees FY2025 Sales $510.000M-$550.000M vs $528.54M Est

eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) reported quarterly earnings of $2.51 per share which beat the analyst consensus estimate of $2.06 by 21.84 percent. This is a 97.64 percent increase over earnings of $1.27 per share from the same period last year. The company reported quarterly sales of $315.18 million which beat the analyst consensus estimate of $284.11 million by 10.94 percent. This is a 27.26 percent increase over sales of $247.66 million the same period last year.

eHealth Q4 EPS $2.51 Beats $2.06 Estimate, Sales $315.18M Beat $284.11M Estimate

AAOI

ABEV

ACMR

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARKO

ASTE

ATEC

AVNS

BATRA

BATRK

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

<h3>Gainers</h3>
<ul>
<li>XChange Tec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHG#NASDAQ">XHG</a>) stock increased by 27.4% to $1.44 during Monday's pre-market session. The market value of their outstanding shares is at $162.1 million. </li>
<li>Stock Yards Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYBT#NASDAQ">SYBT</a>) stock moved upwards by 27.07% to $84.62. The market value of their outstanding shares is at $2.4 billion. </li>
<li>S&amp;T Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBA#NASDAQ">STBA</a>) shares increased by 26.07% to $44.67. The market value of their outstanding shares is at $1.7 billion. </li>
<li>Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) stock moved upwards by 12.46% to $157.18. The market value of their outstanding shares is at $6.5 billion. </li>
<li>Powell Max (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMAX#NASDAQ">PMAX</a>) shares moved upwards by 9.72% to $2.03. The market value of their outstanding shares is at $29.8 million. </li>
<li>Greenpro Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRNQ#NASDAQ">GRNQ</a>) stock increased by 9.52% to $2.07. The company's market cap stands at $15.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>FirstCash Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCFS#NASDAQ">FCFS</a>) shares declined by 29.6% to $75.08 during Monday's pre-market session. The company's market cap stands at $3.3 billion. </li>
<li>RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) shares declined by 11.29% to $221.83. The market value of their outstanding shares is at $11.5 billion. </li>
<li>ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) stock decreased by 9.98% to $12.81. The company's market cap stands at $655.3 million. </li>
<li>Vinci Partners Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VINP#NASDAQ">VINP</a>) shares fell 8.5% to $8.51. The company's market cap stands at $549.9 million. </li>
<li>Hennessy Advisors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNNA#NASDAQ">HNNA</a>) stock decreased by 8.39% to $10.6. The market value of their outstanding shares is at $82.4 million. </li>
<li>eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) shares fell 8.33% to $9.03. The company's market cap stands at $267.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

FCFS

GRNQ

HLNE

HNNA

PMAX

STBA

SYBT

VINP

12 Financials Stocks Moving In Monday's Pre-Market Session

eHealth shares are trading higher after the company raised its full-year revenue outlook and adjusted EBITDA guidance.

eHealth Raises Full-Year Revenue Outlook From $470M-$495M to $500M-$520M vs $487.43M Est.; Raises Adjusted EBITDA Outlook From $7.5M-$25M to $40M-$55M

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Alliance Global Partners analyst Brian Kinstlinger initiated coverage on Bitfarms Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BITF#NASDAQ">BITF</a>) with a Buy rating and announced a price target of $6. Bitfarms shares closed at $1.99 on Tuesday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Jonathan Yong initiated coverage on eHealth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Neutral rating and announced a price target of $5.5. eHealth shares closed at $5.67 on Tuesday. <a href="https://www.benzinga.com/quote/PNW/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Mizuho analyst Steven Valiquette initiated coverage on Veeva Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) with an Outperform rating and announced a price target of $275. Veeva Systems shares closed at $226.46 on Tuesday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst George Notter initiated coverage on Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) with a Buy rating and announced a price target of $135. Coherent shares closed at $106.54 on Tuesday. <a href="https://www.benzinga.com/quote/KR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Jason Butler initiated coverage on ABIVAX Société Anonyme (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABVX#NASDAQ">ABVX</a>) with a Market Outperform rating and announced a price target of $33. Abivax shares closed at $8.30 on Tuesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying VEEV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-1024x584.png" alt="" class="wp-image-676364" style="width:635px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04081129/image-35.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42293707/jim-cramer-prefers-this-delivery-giant-over-ups">Jim Cramer Prefers FedEx Over This Delivery Giant That &#8216;Screwed Up A Lot Of Holiday Seasons&#8217;</a></li>
</ul>

Initiation

Pre-Market Outlook

Markets

Trading Ideas

ABVX

BITF

VEEV

This Veeva Systems Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

UBS analyst Jonathan Yong initiates coverage on eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Neutral rating and announces Price Target of $5.5.

UBS Initiates Coverage On eHealth with Neutral Rating, Announces Price Target of $5.5

RBC Capital analyst Frank Morgan maintains eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) with a Sector Perform and lowers the price target from $13 to $11.

RBC Capital Maintains Sector Perform on eHealth, Lowers Price Target to $11

Craig-Hallum analyst George Sutton upgrades eHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EHTH#NASDAQ">EHTH</a>) from Hold to Buy and raises the price target from $5 to $7.

Upgrades

Craig-Hallum Upgrades eHealth to Buy, Raises Price Target to $7

EHealth shares are trading lower after the company reported worse-than-expected Q3 financial results.

Press Releases

Modivcare Announces Changes to Board of Directors

Management

Fortrea to Add Erin L. Russell to Board of Directors

eHealth, Inc. Announces Fourth Quarter and Fiscal Year 2024 Results

New eHealth Research Finds Americans are Unhappy with the US Healthcare System and Open to New Ideas

eHealth, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

eHealth Supports Final Medicare Advantage Rules and Rates for the Fall 2025 Annual Enrollment Period

eHealth, Inc. to Hold First Quarter 2025 Earnings Call on May 7 at 8:30 a.m. Eastern Time

eHealth Introduces AI Voice Agents to Enhance Customer Experience in Health Plan Selection

eHealth, Inc. Announces First Quarter 2025 Results

eHealth Research Highlights Graduation Season Education Gap: 80% Don't Know Where to Start When It Comes to Health Insurance

Comments

eHealth

Notizie

Ultime notizie per eHealth (NASDAQ:EHTH) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO